Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Toshiba got the cash for its medical biz before the deal closed
Toshiba managed to book the $5.95 billion sale of its medical business to Canon before the deal actually closed, by setting up a holding company with just $300 in assets to skirt Japanese anti-trust regulations.
In March, Toshiba granted Canon exclusive negotiating rights to buy Toshiba Medical Systems after a hotly contested auction. Toshiba badly needed the ¥665.5 billion sale to shore up its business in the face of mounting restructuring costs after a $1.3 billion accounting scandal. Read more
4. Medtronic touts multi-trial In.Pact Admiral data
Medtronic today released a bevy of new data from clinical studies of its In.Pact Admiral drug coated balloon designed for treating peripheral artery disease.
The Fridley, Minn.-based released data from 3 different studies of its In.Pact Admiral DCB at the 2016 Charing Cross Symposium meeting in London, including 1-year results from a chronic total occlusion imaging cohort and 2-year gender and diabetic subgroup analysis. Read more
3. FDA clears Intuity Medical’s Pogo glucose meter
Intuity Medical said today that it won 510(k) clearance from the FDA for its Pogo 1-step glucose meter.
Sunnyvale, Calif.-based Intuity said the device is designed to combine the lancing, blood collection and analysis functions involved in measuring blood glucose into a single step. Read more
2. C.R. Bard settles clutch of pelvic mesh lawsuits
A West Virginia federal judge yesterday dismissed nearly 150 product liability lawsuits brought against C.R. Bard over its pelvic mesh products, after an appeals court earlier this year upheld a $2 million verdict against the company in another suit.
Judge Joseph Goodwin of the U.S. District Court for Southern West Virginia, who’s overseeing the multi-district litigation involving thousands of lawsuits filed against Bard and other mesh makers, dismissed 149 of suits yesterday, according to court documents. The devices are designed to treat female urinary incontinence and pelvic organ prolapse. Medtronic subsidiary Covidien, which supplied the mesh to Bard, was also included in the dismissals. Read more
1. Boston Scientific wins FDA nod for MR-conditional ImageReady pacemaker line
Boston Scientific said yesterday that it won FDA approval for its ImageReady line of MR-conditional pacemakers, including the Accolade MRI and Essentio MRI pacers and the Ingevity MRI leads.
Marlborough, Mass.-based Boston Scientific, which won CE Mark approval in the European Union for the Ingevity leads in March 2014, said the approval covers for full-body, 1.5 Tesla MRI scans for patients implanted with the full ImageReady system, including active and passive fixation models. Read more
